{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:16:11Z","timestamp":1778224571676,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.wneu.2017.01.125","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T17:31:53Z","timestamp":1486747913000},"page":"476-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"101","author":[{"given":"Taiwo","family":"Akhigbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardalan","family":"Zolnourian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik","family":"Bulters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.01.125_bib1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","article-title":"Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends","volume":"78","author":"de Rooij","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2017.01.125_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/124.2.249","article-title":"Subarachnoid haemorrhage: diagnosis, causes and management","volume":"124","author":"van Gijn","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.wneu.2017.01.125_bib3","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.0b013e3181dd42b3","article-title":"Time trends in outcome of subarachnoid haemorrhage: population-based study and systematic review","volume":"74","author":"Lovelock","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.01.125_bib4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid haemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib5","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"3","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.wneu.2017.01.125_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","article-title":"Management of cerebral vasospasm","volume":"29","author":"Macdonald","year":"2006","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2017.01.125_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-211-75718-5_59","article-title":"Role of statins in cerebral vasospasm","volume":"104","author":"Sugawara","year":"2008","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2017.01.125_bib8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1161\/01.STR.0000038986.68044.39","article-title":"Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage","volume":"33","author":"McGirt","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib9","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.STR.0000177879.11607.10","article-title":"Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial","volume":"36","author":"Lynch","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","article-title":"Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial","volume":"36","author":"Tseng","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/STROKEAHA.106.475905","article-title":"Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage","volume":"38","author":"Tseng","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1227\/01.NEU.0000153925.96889.8A","article-title":"Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study","volume":"56","author":"Parra","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.01.125_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1227\/01.neu.0000316009.19012.e3","article-title":"Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage","volume":"62","author":"Kramer","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.01.125_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3171\/2008.10.JNS08901","article-title":"Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study","volume":"110","author":"McGirt","year":"2009","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.01.125_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jocn.2008.08.001","article-title":"Statins may not protect against vasospasm in subarachnoid haemorrhage","volume":"16","author":"Kern","year":"2009","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.01.125_bib16","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1161\/STROKEAHA.107.505875","article-title":"A\u00a0randomised, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage","volume":"39","author":"Chou","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.107.488791","article-title":"Statin treatment and occurrence of haemorrhagic stroke in patients with history of cerebrovascular disease","volume":"39","author":"Vergouwen","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12028-009-9306-9","article-title":"Statins in the management of patients with aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis","volume":"12","author":"Kramer","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2017.01.125_bib19","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/STROKEAHA.107.508341","article-title":"Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis","volume":"39","author":"Sillberg","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2017.01.125_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12028-015-0233-7","article-title":"Effect of high-dose simvastatin on cerebral blood flow and static autoregulation in subarachnoid haemorrhage","volume":"25","author":"Diringer","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2017.01.125_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.wneu.2017.01.125_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Intervention","year":"2011"},{"key":"10.1016\/j.wneu.2017.01.125_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3171\/jns.2006.105.5.671","article-title":"Risk of cerebral vasospasm after subarachnoid haemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience","volume":"105","author":"Mc Grit","year":"2006","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.01.125_bib25","doi-asserted-by":"crossref","first-page":"A80","DOI":"10.1097\/00003246-200612002-00275","article-title":"Safety and feasibility of simvastatin in delayed vasospasm prevention following aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Oglivy","year":"2006","journal-title":"Crit Care Med"},{"issue":"suppl 2","key":"10.1016\/j.wneu.2017.01.125_bib26","doi-asserted-by":"crossref","first-page":"P112","DOI":"10.1186\/cc6333","article-title":"Impact of treatment with pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid haemorrhage","volume":"12","author":"Jaschinski","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.01.125_bib27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/jcbfm.2009.59","article-title":"Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial","volume":"29","author":"Vergouwen","year":"2009","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2017.01.125_bib28","doi-asserted-by":"crossref","first-page":"P103","DOI":"10.1186\/cc7267","article-title":"Effects of simvastatin in prevention of vasospasm in nontraumatic subarachnoid hemorrhage: preliminary data","volume":"13","author":"Macedo","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.01.125_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2017.01.125_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/02688697.2012.757293","article-title":"Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid haemorrhage: a prospective, randomized, double-blind, placebo controlled pilot trial","volume":"27","author":"Garg","year":"2013","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2017.01.125_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trial"},{"key":"10.1016\/j.wneu.2017.01.125_bib32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1161\/STROKEAHA.109.556332","article-title":"Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis update","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib33","doi-asserted-by":"crossref","first-page":"373458","DOI":"10.1155\/2013\/373458","article-title":"Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?","volume":"2013","author":"Lee","year":"2013","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.wneu.2017.01.125_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3171\/JNS-07\/12\/1092","article-title":"Biological effect of acute pravastatin treatment in patients after aneurysmal subarachnoid haemorrhage; double blind placebo controlled trail","volume":"107","author":"Tseng","year":"2007","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.01.125_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/STROKEAHA.114.007006","article-title":"High-dose simvastatin for aneurysmal subarachnoid haemorrhage: multicenter randomized controlled double-blinded clinical trial","volume":"46","author":"Wong","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.01.125_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1474-4422(14)70095-X","article-title":"Are statins to be STASHed in subarachnoid haemorrhage?","volume":"13","author":"Macdonald","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2017.01.125_bib37","article-title":"Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage","volume":"4","author":"Liu","year":"2013","journal-title":"The Cochrane Database Syst Review"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017301547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017301547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T11:25:09Z","timestamp":1536060309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017301547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":37,"alternative-id":["S1878875017301547"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.01.125","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.01.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}